INTEGRITY LABORATORIES, LLC
NPI 1376944793
Clinical Medical Laboratory in Knoxville, TN

Areas of Expertise

The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.

2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r

This service involves the testing for COVID-19 using advanced technologies that can process multiple samples at once. It identifies different types or subtypes of the virus, including SARS-CoV-2/2019-nCoV. This test is non-CDC but adheres to the guidelines outlined in CMS-2020-01-R.

This service was performed 145 times for 139 patients

Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen

This is a lab test that detects the presence of COVID-19 in your body. It uses a technique to amplify the virus's genetic material, either DNA or RNA, making it easier to identify. A positive result indicates an active infection.

This service was performed 218 times for 203 patients

Detection test by nucleic acid for clostridium difficile, amplified probe technique

A detection test by nucleic acid for Clostridium difficile using an amplified probe technique is a lab test that identifies the presence of the Clostridium difficile bacteria in your body. It uses a small sample, often stool, and a technique that amplifies the bacteria's genetic material to confirm its presence.

This service was performed 29 times for 29 patients

Detection test by nucleic acid for digestive tract pathogen, multiple types or subtypes, 3-5 targets

This test identifies harmful organisms in your digestive tract by examining their genetic material. It checks for multiple types of pathogens, targeting 3-5 specific ones. This helps in diagnosing the cause of any digestive issues.

This service was performed 35 times for 35 patients

Detection test by nucleic acid for multiple types influenza virus

A detection test by nucleic acid for multiple types of influenza virus is a diagnostic procedure. It identifies the genetic material of the virus in your body. It's highly accurate and can distinguish between different flu strains, helping in prompt and precise treatment.

This service was performed 103 times for 102 patients

Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets

This test identifies different respiratory viruses by examining their nucleic acid, the building blocks of their genetic material. It can detect multiple types or subtypes, specifically 3-5 targets. This helps in diagnosing your respiratory illness accurately.

This service was performed 36 times for 34 patients

Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique

This test identifies the presence of the Respiratory Syncytial Virus (RSV) in your body. It uses a technique called the amplified probe, which increases the amount of viral genetic material, making it easier to detect. This helps in diagnosing RSV infections accurately.

This service was performed 188 times for 180 patients

Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique

A detection test for Staphylococcus aureus uses a method called the amplified probe technique. This method identifies the bacteria's unique genetic material, or nucleic acid, helping to confirm its presence. It's a highly accurate way to detect this type of bacteria.

This service was performed 16 times for 14 patients

Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique

The detection test by nucleic acid for vancomycin-resistant strep (VRE) is a laboratory procedure. It uses an amplified probe technique to identify specific genetic material in bacteria. This helps determine if the bacteria are resistant to the antibiotic vancomycin.

This service was performed 35 times for 35 patients

Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms

A definitive drug test identifies specific drugs in your system. It uses advanced methods like gc/ms and lc/ms, which can distinguish between different types of drugs but not necessarily their 3D forms. This test offers detailed results to support your healthcare decisions.

This service was performed 166 times for 20 patients

Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within

This is a test to detect the COVID-19 virus. It uses a technique that amplifies the virus's genetic material (DNA or RNA) for detection. High throughput technologies are used for rapid and large-scale testing. The procedure is completed within a set time frame.

This service was performed 144 times for 138 patients

Testing for presence of drug, by chemistry analyzers

Chemistry analyzers are used to detect the presence of drugs in your system. This test involves taking a small sample of your blood or urine. The sample is then analyzed for specific substances. The results help in understanding your health condition better.

This service was performed 155 times for 26 patients

CLIA Information

The Clinical Laboratory Improvement Amendments (CLIA) of 1988 applies to facilities or sites that test human specimens for health assessment or to diagnose, prevent, or treat disease. The CLIA Program sets standards for clinical laboratory testing and issues certificates. The NPI / CLIA crosswalk information for this NPI number is:

CLIA Number

44D2082509

Facility Type

Independent

Certificate Effective Date

August 02, 2024

Certificate Expiration Date

August 01, 2026

Laboratory Director

DR. JIM H. VINSON

Certificate Type

Certificate of Accreditation

Certificate Type Description

This is a CLIA certificate is issued to Integrity Laboratories, Llc on the basis of the laboratory's accreditation by an accreditation organization approved by CMS. This type of certificate is issued to a laboratories tha perform nonwaived (moderate and/or high complexity) testing.

Reviews for INTEGRITY LABORATORIES, LLC

There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.

Frequently Asked Questions